申请人:Mitsubishi Chemical Corporation
公开号:EP0434070A2
公开(公告)日:1991-06-26
A novel pyrrolealdehyde derivative represented by the following formula (I):
wherein R represents C₁₀-C₁₆ alkyl unsubstituted or substituted by at least one substituent selected from the group consisting of halo, hydroxy, amino, carbamoyl, C₁-C₅ alkylamino, C₂-C₆ dialkylamino, C₂-C₆ acylamino, C₁-C₅ alkylthio, mercapto, C₂-C₆ acyloxy, carbamoyloxy, C₆-C₁₂ aryl and C₃-C₇ cycloalkyl; or C₁₀-C₁₆ alkenyl having at least one vinyl,
and a pharmaceutically acceptable salt thereof are provided. The compounds are highly effective in reducing the level of triglyceride and cholesterol in serum, and useful as an active ingredient of a pharmaceutical composition for treating hyperlipemia and arteriosclerosis.
由下式(I)代表的新型吡咯醛衍生物:
C₁-C₅烷基氨基、C₂-C₆ 二烷基氨基、C₂-C₆酰氨基、C₁-C₅烷硫基、巯基、C₂-C₆酰氧基、氨基甲酰氧基、C₆-C₁₂芳基和 C₃-C₇环烷基;或具有至少一个乙烯基的 C₁₀-C₁₆ 烯基、
及其药学上可接受的盐。这些化合物在降低血清中甘油三酯和胆固醇水平方面非常有效,可用作治疗高脂血症和动脉硬化的药物组合物的活性成分。